Skip Navigation

European Heart Journal 2002 23(7):517-520; doi:10.1053/euhj.2001.3049
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Muir, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muir, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Enterovirus infection of the heart—a causal or contributory factor in chronic rheumatic heart disease?

P. Muir

Department of Infectious Diseases, Kings College London, London, U.K.

References

  1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13:470–511[Abstract/Free Full Text]
  2. Majeed HA, Batnager S, Yousof AM, Khuffash F, Yusuf AR. Acute rheumatic fever and the evolution of rheumatic heart disease: a prospective 12 year follow-up report. J Clin Epidemiol. 1992;45:871–875[CrossRef][Web of Science][Medline]
  3. Baboonian C, Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart. 1997;78:539–543[Abstract/Free Full Text]
  4. Horwitz MS, La Cava A, Fine C. Pancreatic expression of interferon-{gamma} protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nature Med. 2000;6:693–697[CrossRef][Web of Science][Medline]
  5. Brown LJ, Illavia SJ, Hayat SA, Banatvala JE, Muir P. Viral persistence and antigen expression in coxsackievirus-induced acute and chronic murine myocarditis. J Clin Virol. 2001;22:150–151
  6. Li Y, Pan Z, Ji Y, Peng T, Archard LC, Zhang H. Enterovirus replication in valvular tissue from patients with chronic rheumatic heart disease. Eur Heart J. 2002;23:567–573[Abstract/Free Full Text]
  7. Li YW, Bourlet T, Andreoletti L. Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis and dilated cardiomyopathy. Circulation. 2000;101:231–234[Abstract/Free Full Text]
  8. Zhang H, Li Y, Peng T. Localization of enteroviral antigen in myocardium and other tissues from patients with heart muscle disease by an improved immunohistochemical technique. J Histochem Cytochem. 2000;48:579–584[Abstract/Free Full Text]
  9. Li YW, Yang YZ, Chen HZ. Relationship between enteroviral infection and chronic rheumatic valvular disease. Chin J Exp Surg. 1997;14:163–164
  10. Li Y, Peng T, Yang Y. High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart. 2000;83:696–701[Abstract/Free Full Text]
  11. Beck MA, Shi Q, Morris VC, Levander OA. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Med. 1995;1:433–436[CrossRef][Web of Science][Medline]
  12. Roberts S, Kosanke S, Dunn ST. Pathogenic mechanisms in rheumatic carditis: Focus on valvular endothelium. J Infect Dis. 2001;183:507–511[CrossRef][Web of Science][Medline]
  13. Chonmaitree T, Mann L. Respiratory infections. Rotbart HA. Human enterovirus infections. Washington: ASM Press; 1995. p. 255–270
  14. Pankuweit S, Portig I, Lottspeich F, Maisch B. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol. 1997;29:77–84[CrossRef][Web of Science][Medline]
  15. Cunningham MW, Antone SM, Gulizia JM. Cytotoxic and viral neutralizing antibodies cross react with streptococcal M protein, enteroviruses and human cardiac myosin. Proc Natl Acad Sci USA. 1992;89:1320–1324[Abstract/Free Full Text]
  16. Horwitz MS, Bradley LM, Harbertson J. Diabetes induced by coxsackievirus: Initiation by bystander damage and not molecular mimicry. Nature Med. 1998;4:781–785[CrossRef][Web of Science][Medline]
  17. Luppi P, Rudert WA, Zanone MM. Idiopathic dilated cardiomyopathy: a superantigen-driven autoimmune disease. Circulation. 1998;98:777–785[Abstract/Free Full Text]
  18. Luppi P, Licata A, Haluszczak C. Analysis of TCR Vß repertoire and cytokine gene expression in patients with idiopathic dilated cardiomyopathy. J Autoimmun. 2001;16:3–13[CrossRef][Web of Science][Medline]
  19. Michie CA, Cohen J. The clinical significance of T-cell superantigens. Trends Microbiol. 1998;6:61–65[CrossRef][Web of Science][Medline]
  20. Papageorgiou AC, Acharya KR. Microbial superantigens: from structure to function. Trends Microbiol. 2000;8:369–375[CrossRef][Web of Science][Medline]
  21. Schiffenbauer J, Joohnson HM, Butfiloski EJ, Wegrzyn L, Soos JM. Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci USA. 1993;90:8543–8546[Abstract/Free Full Text]
  22. Paliard X, West SG, Lafferty JA. Evidence for the effects of a superantigen in rheumatoid arthritis. Science. 1991;253:325–329[Abstract/Free Full Text]
  23. Conrad B, Weidmann E, Trucco G. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature. 1994;371:351–355[CrossRef][Medline]
  24. Guilherme L, Dulphy N, Douay C. Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. Int Immunol. 2000;12:1063–1074[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur J Heart FailHome page
F. Waagstein, O. Stromblad, B. Andersson, M. Bohm, M. Darius, W. Delius, F. Goss, K.J. Osterziel, M. Sigmund, S.-P. Trenkwalder, et al.
Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy
Eur J Heart Fail, October 1, 2003; 5(5): 679 - 691.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Muir, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muir, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?